Dian Zhong Luo


Country: China


  1. request reprint
    Liu J, Chen G, Dang Y, Li C, Luo D. Expression and prognostic significance of lncRNA MALAT1 in pancreatic cancer tissues. Asian Pac J Cancer Prev. 2014;15:2971-7 pubmed
    ..MALAT1 might be considered as a potential prognostic indicator and may be a target for diagnosis and gene therapy for PDAC. ..
  2. request reprint
    Liu J, Peng W, Mo Y, Luo D. MALAT1-mediated tumorigenesis. Front Biosci (Landmark Ed). 2017;22:66-80 pubmed
    ..In this review, we first update on the role of MALAT1 in tumorigenesis and then discuss possible molecular mechanisms that underline the MALAT1-mediated gene regulation, leading to cancer invasion and metastasis. ..
  3. Zhang Y, Chen W, Gan T, Zhang X, Xie Z, Ye Z, et al. Clinical Significance and Effect of lncRNA HOXA11-AS in NSCLC: A Study Based on Bioinformatics, In Vitro and in Vivo Verification. Sci Rep. 2017;7:5567 pubmed publisher
    ..These results indicate that HOXA11-AS plays pivotal roles in NSCLC and it can become a novel therapeutic direction for treating NSCLC. ..
  4. Ren F, Yang H, He R, Lu J, Lin X, Liang H, et al. Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma. BMC Cancer. 2018;18:12 pubmed publisher
    ..And the experiments in vivo and vitro will be conducted by our group to identify the specific mechanism of miR-34a in the progress and deterioration of HCC. ..
  5. He R, Li X, Liang L, Xie Y, Luo D, Ma J, et al. The suppressive role of miR-542-5p in NSCLC: the evidence from clinical data and in vivo validation using a chick chorioallantoic membrane model. BMC Cancer. 2017;17:655 pubmed publisher
    ..This evidence suggests that miR-542-5p is a potential tumor-suppressed miRNA in NSCLC, which has the potential to act as a diagnostic and therapeutic target of NSCLC. ..